Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Astellas Pharma Singapore Pte. Ltd.

Clinical trials sponsored by Astellas Pharma Singapore Pte. Ltd., explained in plain language.

Drug shows promise in keeping aggressive leukemia at bay after transplant

Disease control Completed

This study looked at whether the drug gilteritinib helps keep acute myeloid leukemia (AML) from returning after a stem cell transplant in patients with a specific genetic change (FLT3). Researchers compared two groups: one from previous trials who received gilteritinib after tran…

Sponsor: Astellas Pharma Singapore Pte. Ltd. • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC